Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.
- Published In:
- European journal of pharmacology, 701(1-3), 203-12 (2013)
- Authors:
- Cesarec, Vedran(2), Becejac, Tomislav, Misic, Marija, Djakovic, Zeljko, Olujic, Danijela, Drmic, Domagoj, Brcic, Luka, Rokotov, Dinko Stancic, Seiwerth, Sven, Sikiric, Predrag
- Database ID:
- RPEP-02145
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02145APA
Cesarec, Vedran; Becejac, Tomislav; Misic, Marija; Djakovic, Zeljko; Olujic, Danijela; Drmic, Domagoj; Brcic, Luka; Rokotov, Dinko Stancic; Seiwerth, Sven; Sikiric, Predrag. (2013). Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.. European journal of pharmacology, 701(1-3), 203-12. https://doi.org/10.1016/j.ejphar.2012.11.055
MLA
Cesarec, Vedran, et al. "Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.." European journal of pharmacology, 2013. https://doi.org/10.1016/j.ejphar.2012.11.055
RethinkPeptides
RethinkPeptides Research Database. "Pentadecapeptide BPC 157 and the esophagocutaneous fistula h..." RPEP-02145. Retrieved from https://rethinkpeptides.com/research/cesarec-2013-pentadecapeptide-bpc-157-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.